Urovant Sciences is a biopharmaceutical company focused on developing and commercializing innovative therapies for urologic conditions. We exist to advance patient care through bold innovation, with the goal of becoming the leading specialty company recognized and trusted by patients and providers for our commitment to urology. Urovant Sciences, a subsidiary of Sumitomo Dainippon Pharma Co., Ltd., intends to develop novel treatments for additional urologic diseases. Learn more about us at www.urovant.com.
Corporate Partner Level
Gold Strategic Partner